| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 08/23/2007 | US20070196270 Compounds As Ccri Antagonists |
| 08/23/2007 | DE102006008772A1 Hydroxymatairesinol gegen trockene Haut Hydroxymatairesinol dry skin |
| 08/23/2007 | CA2652648A1 Dihydrodiazepines useful as inhibitors of protein kinases |
| 08/23/2007 | CA2640283A1 High dosage of mycophenolic acid (mpa) |
| 08/23/2007 | CA2635430A1 Use of a pcv2 immunogenic composition for lessening clinical symptoms in pigs |
| 08/22/2007 | EP1820861A2 C3B/C4B complement receptor-like molecules and uses thereof |
| 08/22/2007 | EP1820855A1 Anti-histone h1 monoclonal antibody and hybridoma capable of producing the same |
| 08/22/2007 | EP1820805A2 Inhibitor and stimulator of haemotopoietic stem cell proliferation and uses thereof |
| 08/22/2007 | EP1820514A2 Therapeutic compositions that produce an immune response by altering the antigen |
| 08/22/2007 | EP1820503A2 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 08/22/2007 | EP1819352A1 Pharmaceutical compositions from carapa guianensis |
| 08/22/2007 | EP1819341A2 Il-12 modulatory compounds |
| 08/22/2007 | EP1819326A1 Dosage regimen of an s1p receptor agonist |
| 08/22/2007 | EP1631586B1 Peptide analogues comprising at least one type of aminoacyl aza-beta 3 and the use thereof, in particular for therapy |
| 08/22/2007 | EP1499320B1 Novel compounds |
| 08/22/2007 | EP1490405B1 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF |
| 08/22/2007 | EP1399433B1 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 08/22/2007 | EP1333851B1 Selfemulsifiable formulation having enhanced bioabsorption and immunosuppression activities |
| 08/22/2007 | EP1326961B1 Compositions and methods for inducing specific cytolytic t cell responses |
| 08/22/2007 | EP1303292A4 Chemokine conjugates |
| 08/22/2007 | EP1227813B1 REVERSE-TURN MIMETICS AS alpha 4ß INTEGRIN INHIBITORS |
| 08/22/2007 | EP1178952B1 Novel interleukin-1 and tumor necrosis factor-alpha modulators, syntheses of said modulators and methods of using said modulators |
| 08/22/2007 | EP1150970B1 (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same |
| 08/22/2007 | EP1017846B1 Control of immune responses by modulating activity of glycosyltransferases |
| 08/22/2007 | EP0877555B1 Use of an inhibitor of an immune system costimulation event for the preparation of a medicament inhibiting the immune system destruction of transplanted viable non-embryonic cells |
| 08/22/2007 | CN1332961C Inhibitors of alpha L beta 2 mediated cell adhesion |
| 08/22/2007 | CN1332952C 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) im |
| 08/22/2007 | CN1332714C Method for treating fibrosis by utilizing integrin alpha 4 subunit antagonist |
| 08/22/2007 | CN1332693C Compound Chinese herbal immunopotentiator for juvenile of paralichthys olivaceus |
| 08/22/2007 | CN1332675C Medicine application of catalpa and extractive for anti allergic disease |
| 08/22/2007 | CN1332668C Cepharanthine slow releasing preparation |
| 08/22/2007 | CN101023103A Virus-like particles comprising a fusion protein of the coat protein of ap205 and an antigenic polypeptide |
| 08/22/2007 | CN101022826A Bacterial compositions for the treatment of cancer |
| 08/22/2007 | CN101022809A Dihydropteridinones for the treatment of cancer diseases |
| 08/22/2007 | CN101020037A Wet sterilized towel used for couple's sexual life and its making process |
| 08/22/2007 | CN101020029A Health wine with functions of resisting fatigue and regulating and enhancing immunity |
| 08/22/2007 | CN101020026A Honeyed Guiqi ointment for enhancing body's resistance and its prepn |
| 08/22/2007 | CN101019983A Chinese medicine for treating allergic purpura |
| 08/22/2007 | CN101019940A Organic composite Chinese medicine immunopotentiator/adjuvant and its prepn process |
| 08/22/2007 | CN101019920A Chinese medicine composition soft capsule possessing immunopotentiation function |
| 08/22/2007 | CN101019911A Chinese medicine composition possessing antifatigue and immunoregulation functions |
| 08/22/2007 | CN101019909A Supercritical safflower extracting process |
| 08/22/2007 | CN101019899A Buccal tablet of aweto or aweto extract |
| 08/22/2007 | CN101019885A Compound ginseng-astragalus immunopotentiator |
| 08/22/2007 | CN101019853A Composition containing dihomo-gamma-linolenic acid (DGLA) as the active ingredient |
| 08/22/2007 | CN101019845A Sodium myristyl aldehyde sulfate and its application as immunoadjuvant |
| 08/22/2007 | CN101019821A Desensitizing anticarious gel and its prepn |
| 08/22/2007 | CN101019643A Bown sugar health product capable of raising women's immunity |
| 08/22/2007 | CN101019642A Brown sugar health product capable of raising immunity of puerpera |
| 08/22/2007 | CN101019612A Orally taken health product for eliminating fatigue of racing pigeon |
| 08/22/2007 | CN101019598A Cold drink product capable of improving intestinal tract function |
| 08/21/2007 | US7259247 Against the costimulatory surface molecule, natural or synthetic ligands, agonists or antagonists of the surface molecule. |
| 08/21/2007 | US7259187 Tropolone derivatives |
| 08/21/2007 | US7259179 Kinase inhibitors |
| 08/21/2007 | US7259173 Derivatives of 3-phenyl-n-(2-(4-benzyl)-piperidin-1-yl)-ethyl)-acrylamid with ccr-3-receptor antagonistic activity for use in the treatment of inflammations and allergic conditions |
| 08/21/2007 | US7259170 Macrolides containing pharmaceutical compositions |
| 08/21/2007 | US7259162 Benzazole derivatives and their use as JNK modulators |
| 08/21/2007 | US7259161 For therapy of immune response, an autoimmune disease, a neurodegenerative, or a solid or hematologic malignancy |
| 08/21/2007 | US7259154 Pyrrolopyrimidines |
| 08/21/2007 | US7259148 Hepatoprotective activity of 2′-p-hydroxybenzoylmussaenosidic acid |
| 08/21/2007 | US7259147 treating multiple sclerosisbby administering an inhibitor of JTT-1 antigen activity. |
| 08/21/2007 | US7259137 Tumor necrosis factors; cytokines; immunoglobulins; autoimmune diseases |
| 08/21/2007 | US7258872 Chromone enteric release formulation |
| 08/21/2007 | US7258859 Method for the treatment of multiple sclerosis |
| 08/21/2007 | CA2150940C Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis |
| 08/21/2007 | CA2099589C Enantiomerically pure .beta.-d-(-)-dioxolane-nucleosides |
| 08/21/2007 | CA2070004C Cloned glutamic acid decarboxylase |
| 08/16/2007 | WO2007092190A2 Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity |
| 08/16/2007 | WO2007091919A1 Method for treating chronic illnesses (variants), method for producing a biograft (variants) and a biograft (variants) |
| 08/16/2007 | WO2007091570A1 Binding inhibitor of sphingosine-1-phosphate |
| 08/16/2007 | WO2007091396A1 Novel amidopropionic acid derivative and pharmaceutical product containing same |
| 08/16/2007 | WO2007091387A1 Hla-binding peptide, precursor thereof, dna fragment encoding the same and recombinant vector |
| 08/16/2007 | WO2007091313A1 Cytokine production inhibitor and heterocyclic phenoxy derivative |
| 08/16/2007 | WO2007090569A1 Conditioned blood composition and method for its production |
| 08/16/2007 | WO2007072017A3 Enzyme inhibitors |
| 08/16/2007 | WO2007071442A3 Inhibitors of ccr9 activity |
| 08/16/2007 | WO2007007919A3 Heterocyclic janus kinase 3 inhibitors |
| 08/16/2007 | WO2006115509A3 Small molecule immunopotentiators and assays for their detection |
| 08/16/2007 | WO2004007437A9 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments |
| 08/16/2007 | WO2000000156A3 Methods for modulating immunological responses by targeting antigen to apcs in conjuction with anti-cd40 ligands |
| 08/16/2007 | US20070192906 Rice plant having vaccine gene transferred thereinto |
| 08/16/2007 | US20070191468 Amino alcohol compound |
| 08/16/2007 | US20070191428 Anhydrous crystalline fexofenadine hydrochloride Form C, crystalline fexofenadine acetate monohydrate Form D, crystalline fexofenadine acetate dihydrate Form E, crystalline fexofenadine free base monohydrate Form F; H1 receptor antagonist; antihistaminic drug; reduction of ketonic form, salt formation |
| 08/16/2007 | US20070191401 Transplant rejection, autoimmune disease, autoimmune disease |
| 08/16/2007 | US20070191392 Dipeptide nitrile cathespin k inhibitors |
| 08/16/2007 | US20070191388 1-Benzyl-4-[4-(thiophene-2-carbonyl) piperazin-1-yl]-2-oxo-1,2-dihydro-3-cyano[1,8]-naphthyridine; antinflammatory, antiarthritic, anticarcinogenic, antitumor, antidiabetic; septic shock; acute respiratory distress syndrome; casrdiovascular disorders; angiogenesis inhibitors; autoimmune diseases; asthma |
| 08/16/2007 | US20070191386 Bicyclo-pyrazole compounds specially pyrrolo[3,4-c]pyrazole or tetrahydropyridine[4,3-c]pyrazole derivatives; anticarcinogenic agents; N-{5-phenylacetyl-4,6-dihydropyrrolo[3,4-c]pyrazol-3-yl}phenylacetamide; modulators of apoptosis; combinatorial chemical library with an isocyanate polystyrenic resin |
| 08/16/2007 | US20070191328 Isoquinoline compounds |
| 08/16/2007 | US20070191299 Extension Of The Expression of Transgenic Proteins By Immunomodulation |
| 08/16/2007 | US20070191278 Cd8 as an inhibitor of the cellular immune system |
| 08/16/2007 | US20070191265 Anti-HIV Agent |
| 08/16/2007 | US20070190652 Anti-HIV Agent |
| 08/16/2007 | US20070190634 Compositions useful as inhibitors of protein kinases |
| 08/16/2007 | US20070190612 31 Human Secreted Proteins |
| 08/16/2007 | US20070190567 Treatment for asthma and allergy |
| 08/16/2007 | US20070190132 Pharmaceutical compositions for oral and topical administration |
| 08/16/2007 | US20070190120 Administration of non-oral androgenic steroids to women |
| 08/16/2007 | US20070190112 Treating neovascularization by placing bioerodible drug delivery system comprising an immunosuppressive agent and a bioerodible polymer (glycolic acid-lactic acid copolymer); sustained release |
| 08/16/2007 | US20070190106 Phosphorus-containing compounds & uses thereof |
| 08/16/2007 | US20070190078 Filamentous haemagglutinin in the treatment and/or prophylaxis of immune-mediated disorders |